INNOVIVA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.84 USD | -1.68% |
|
+1.80% | -1.25% |
| May. 08 | Earnings Flash (INVA) INNOVIVA Posts Q1 Revenue $77.5M | MT |
| May. 08 | Innoviva, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presenter SpeechVikram Purohit (Analysts)Thanks, everyone, for joining us. I think we should g...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Innoviva, Inc. is a diversified holding company with a portfolio of royalties and other healthcare assets. The Company's royalty portfolio consists of respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI) and ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI). Under the Long-Acting Beta2 Agonist (LABA) Collaboration Agreement, the Company is entitled to receive royalties from GSK on sales of RELVAR/BREO ELLIPTA. The Company's products include GIAPREZA and XERAVA. GIAPREZA (angiotensin II) injection is approved by the United States Food and Drug Administration (FDA) as a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. XERAV (eravacycline) for injection is approved by the United States FDA and Singapore Health Sciences Authority (HSA) as a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections (cIAI).
Sector
Pharmaceuticals
Calendar
2024-07-23
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
15.84
USD
Average target price
16
USD
Spread / Average Target
+1.01%
| 1st Jan change | Capi. | |
|---|---|---|
| -1.25% | 989M | |
| +35.01% | 709B | |
| +30.65% | 595B | |
| -2.60% | 367B | |
| +20.83% | 334B | |
| +5.69% | 289B | |
| +14.57% | 239B | |
| +9.41% | 211B | |
| -3.60% | 203B | |
| +10.77% | 171B |
- Stock Market
- Equities
- INVA Stock
- News Innoviva, Inc.
- Transcript : Innoviva, Inc. Presents at Morgan Stanley 15th Annual Global Healthcare Conference, Sep-12-2017 01